Welcome to the ESMO Gynaecological Cancers Congress 2022 Welcome and closure

Welcome to the ESMO Gynaecological Cancers Congress 2022

Lecture Time
08:30 - 08:35
Speakers
  • The Panelists (Valencia, Spain)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
08:25 - 08:30
Management of endometrial cancer in the molecular era Educational session

Introduction

Lecture Time
08:30 - 08:35
Speakers
  • Mansoor Raza Mirza (Copenhagen, Denmark)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
08:30 - 10:00
Management of endometrial cancer in the molecular era Educational session

Recent developments in surgery for early-stage disease

Lecture Time
08:35 - 09:00
Speakers
  • Christian Marth (Innsbruck, Austria)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
08:30 - 10:00
Management of endometrial cancer in the molecular era Educational session

Recent developments in adjuvant treatment

Lecture Time
09:00 - 09:25
Speakers
  • Carien L. Creutzberg (Leiden, Netherlands)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
08:30 - 10:00
Management of endometrial cancer in the molecular era Educational session

New treatment options for advanced and metastatic disease

Lecture Time
09:25 - 09:50
Speakers
  • Alexandra Leary (Villejuif, France)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
08:30 - 10:00
Management of endometrial cancer in the molecular era Educational session

Live Q&A

Lecture Time
09:50 - 10:00
Speakers
  • Carien L. Creutzberg (Leiden, Netherlands)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
08:30 - 10:00
Biomarkers in clinical practice and future perspective for gynaecological cancers Special session

Should we really use PD-L1 as a selection driver in cervical cancer?

Lecture Time
10:30 - 10:50
Speakers
  • Bradley J. Monk (Phoenix, AZ, United States of America)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
10:30 - 12:00
Biomarkers in clinical practice and future perspective for gynaecological cancers Special session

MMR status, TMB or both: How to identify endometrial cancer patients who benefit the most from immunotherapy

Lecture Time
10:50 - 11:10
Speakers
  • Vicky Makker (New York City, NY, United States of America)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
10:30 - 12:00
Biomarkers in clinical practice and future perspective for gynaecological cancers Special session

Digging into molecular characterization of high-grade ovarian cancer: BRCA, HRD and beyond

Lecture Time
11:10 - 11:30
Speakers
  • Nicole Concin (Innsbruck, Austria)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
10:30 - 12:00
Biomarkers in clinical practice and future perspective for gynaecological cancers Special session

The role of MAPK pathway to select therapy in low-grade ovarian cancer

Lecture Time
11:30 - 11:50
Speakers
  • Susana Banerjee (London, United Kingdom)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
10:30 - 12:00
Biomarkers in clinical practice and future perspective for gynaecological cancers Special session

Live Q&A

Lecture Time
11:50 - 12:00
Speakers
  • Bradley J. Monk (Phoenix, AZ, United States of America)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
10:30 - 12:00
Poster Display session Poster Display session

7P - Improving Cervical Cancer Screening in Rural India Over a 5 Year Period by Training Paramedical Staff To Use Visual Inspection with Acetic Acid and Thermal Ablation: A Comparison of Cervical Cancer Rates Between Villages With and Without Training

Presentation Number
7P
Lecture Time
12:55 - 13:00
Speakers
  • Sasmith R. Menakuru (Muncie, IN, United States of America)
Session Name
Room
Exhibition area
Date
Fri, 17.06.2022
Time
12:15 - 13:00

Abstract

Background

Cervical cancer is one of the leading cancers among women in India, and there is an increased need for screening as morbidity and mortality from the malignancy can be prevented. The prevention and control of cervical cancer requires a multidisciplinary effort to not only improve awareness but also to establish primary and secondary prevention strategies. As the population in remote villages do not have ease of access to major hospitals, the training of paramedical staff may be a viable option for screening women for cervical cancer.

Methods

19 rural villages with a combined population of 21,798 of whom 4121 were women above the age of 21 who never underwent screening for cervical cancer were selected. 10 villages with a population of 2113 females were willing to partake in the training of paramedical staff to screen for cervical cancer. The results of the number of positives and false positives were recorded over a 5-year span. The other 9 villages with a female population of 1968 that opted out of training paramedical staff were also followed during the same time period. Women who tested positive on VIA were treated with thermal ablation or referred to a higher medical center.

Results

Of the 2113 women screened for cervical cancer by paramedical staff, VIA came back positive in 19.64%. It was found that on biopsy 1.7% had high grade intraepithelial and 1.17% had low grade intraepithelial. 1.98% had cervical intraepitheial neoplasia stage 2 and above. In the 9 villages where training was not done the rates of screening were poor as only 20 women were screened.

Conclusions

There is an ever-growing need for cervical cancer screening in the rural areas of India, and the authors believe that screening through the usage of paramedical staff may be a good option as VIA and thermal ablation are easily done. Our results show that the overall diagnosis rates and the uptake of screening was more in villages with paramedical staff. We believe the implementation of paramedical staff who are trained in VIA and thermal ablation would ultimately lead to a reduction in the rates of cervical cancer and would better health for women in the rural areas.

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

Collapse